Hepatocellular carcinoma Clinical Trials

Delta Trials indexes 1,600 clinical trials for Hepatocellular carcinoma in its publicly accessible dataset. Of these, 289 enrolling participants at this time and 510 trials have reached completion. This research takes place spanning 1,623 research sites around the world. An additional 801 trials are in preparatory or other active non-recruiting stages. Since 2020, 154 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.